MOREPEN LABORATORIES
Quarterly Results Analysis [Dec2023]
MOREPEN LABORATORIES Quarterly Results
Consolidated | Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
Sep2022 Audited |
Jun2022 Audited |
Mar2022 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹445 Cr | ₹422 Cr | ₹401 Cr | ₹364 Cr | ₹348 Cr | ₹403 Cr | ₹302 Cr | ₹368 Cr |
Expenses | ₹394 Cr | ₹388 Cr | ₹375 Cr | ₹348 Cr | ₹328 Cr | ₹374 Cr | ₹288 Cr | ₹350 Cr |
Operating Income | ₹51 Cr | ₹34 Cr | ₹26 Cr | ₹16 Cr | ₹21 Cr | ₹29 Cr | ₹15 Cr | ₹19 Cr |
Other Income | ₹4 Cr | ₹3 Cr | ₹2 Cr | ₹3 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹3 Cr |
Interest | ₹2 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr |
Depreciation | ₹8 Cr | ₹8 Cr | ₹8 Cr | ₹7 Cr | ₹7 Cr | ₹7 Cr | ₹7 Cr | ₹7 Cr |
Profit Before Tax | ₹44 Cr | ₹29 Cr | ₹21 Cr | ₹11 Cr | ₹14 Cr | ₹22 Cr | ₹8 Cr | ₹14 Cr |
Profit After Tax | ₹32 Cr | ₹21 Cr | ₹15 Cr | ₹8 Cr | ₹9 Cr | ₹16 Cr | ₹6 Cr | ₹12 Cr |
EPS | ₹0.63 | ₹0.42 | ₹0.29 | ₹0.16 | ₹0.18 | ₹0.31 | ₹0.11 | ₹0.26 |
Industry Peers & Returns | 1W | 1M | 1Y |
MOREPEN LABORATORIES | 2.4% | -21.3% | 72.3% |
SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
CIPLA | 2.5% | 0.4% | 71.7% |
DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
MANKIND PHARMA | NA | NA | NA |
TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
LUPIN | 2.8% | 0% | 147.8% |
MOREPEN LABORATORIES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 5.40 % |
Y-o-Y | 27.57 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹445 Cr | 5.40 | |
Sep2023 | ₹422 Cr | 5.17 | |
Jun2023 | ₹401 Cr | 10.27 | |
Mar2023 | ₹364 Cr | 4.37 | |
Dec2022 | ₹348 Cr | -13.53 | |
Sep2022 | ₹403 Cr | 33.26 | |
Jun2022 | ₹302 Cr | -17.89 | |
Mar2022 | ₹368 Cr | - |
MOREPEN LABORATORIES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 50.54 % |
Y-o-Y | 146.43 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹51 Cr | 50.54 | |
Sep2023 | ₹34 Cr | 28.76 | |
Jun2023 | ₹26 Cr | 67.68 | |
Mar2023 | ₹16 Cr | -24.18 | |
Dec2022 | ₹21 Cr | -29.02 | |
Sep2022 | ₹29 Cr | 98.74 | |
Jun2022 | ₹15 Cr | -22.11 | |
Mar2022 | ₹19 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 42.84 % |
Y-o-Y | 93.04 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | 11.37% | 42.84 | |
Sep2023 | 7.96% | 22.27 | |
Jun2023 | 6.51% | 52.10 | |
Mar2023 | 4.28% | -27.33 | |
Dec2022 | 5.89% | -17.85 | |
Sep2022 | 7.17% | 49.06 | |
Jun2022 | 4.81% | -5.13 | |
Mar2022 | 5.07% | - |
MOREPEN LABORATORIES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 50.50 % |
Y-o-Y | 255.69 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹32 Cr | 50.50 | |
Sep2023 | ₹21 Cr | 45.27 | |
Jun2023 | ₹15 Cr | 77.55 | |
Mar2023 | ₹8 Cr | -8.37 | |
Dec2022 | ₹9 Cr | -43.11 | |
Sep2022 | ₹16 Cr | 180.82 | |
Jun2022 | ₹6 Cr | -54.31 | |
Mar2022 | ₹12 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 42.86 % |
Y-o-Y | 179.07 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | 7.2 % | 42.86 | |
Sep2023 | 5.04 % | 38.08 | |
Jun2023 | 3.65 % | 60.79 | |
Mar2023 | 2.27 % | -12.02 | |
Dec2022 | 2.58 % | -34.18 | |
Sep2022 | 3.92 % | 110.75 | |
Jun2022 | 1.86 % | -44.48 | |
Mar2022 | 3.35 % | - |
MOREPEN LABORATORIES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 50.00 % |
Y-o-Y | 250.00 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹0.63 | 50.00 | |
Sep2023 | ₹0.42 | 44.83 | |
Jun2023 | ₹0.29 | 81.25 | |
Mar2023 | ₹0.16 | -11.11 | |
Dec2022 | ₹0.18 | -41.94 | |
Sep2022 | ₹0.31 | 181.82 | |
Jun2022 | ₹0.11 | -57.69 | |
Mar2022 | ₹0.26 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD